Ask Anything
Hot Research Today
Papers from every journal, all in one place. Create custom feeds.
RCT · n=1,07913 mentionsTrending on XExpert Commentary
JUL 1SotomiThe Lancet
One-month dual antithrombotic therapy is non-inferior to 12 months for major events in AF patients post-PCI.
1-month dual therapy noninferior with less bleeding after PCI in AF; extends abbreviated DAT evidence for this population.
DYDr. Yohei Sotomi
Cardiologist, University of Osaka Graduate School of Medicine
Patients with atrial fibrillation who receive a stent may only need 1 month of dual antithrombotic therapy, instead of 1 year. This shorter treatment is just as effective and much safer in terms of bleeding.
RCT8 mentionsExpert CommentaryACC Journal Scan Highlight
JUL 13MahéCirculation
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial
Randomized trial evaluates the prognosis of recurrent thromboembolism in cancer patients on apixaban, suggesting important treatment considerations.
DMDr. Marc Carrier
Professor, Ottawa Hospital Research Institute
Exciting results presented by Prof Isabelle Mahé at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris, with simultaneous publication in Circulation. Key findings from this pre-specified ancillary analysis of the API-CAT trial include: Recurrent VTE during extended apixaban therapy was uncommon, occurring in only 2.5% of 1,766 patients over 12 months.
Guideline16 mentionsExpert CommentaryAHA Professional Heart Daily Highlight
JUL 9FlegCirculation
Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association
Warrants individualized exercise regimens for high-risk groups; leaves open optimal protocols pending targeted trials.
GF
Guideline11 mentionsExpert CommentaryAHA Professional Heart Daily Highlight
JUL 8DiDomenicoCirculation
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association
Supports deprescribing assessment in CVD polypharmacy across ages; extends prior evidence beyond older adults to the full lifespan.
cohort · n=1,1226 mentionsTrending on XExpert Commentary
JUL 22SteinJACC Advances
T-TEER is linked to ~83% fewer procedural complications than TTVA but similar 1-year major events.
Comparative outcomes of T-TEER versus TTVA remain limited; leaves open optimal repair strategy in secondary TR.
AJACC Journal Scan
These findings highlight the importance of procedural safety and durable TR reduction, while underscoring the complexity of translating procedural success into early clinical benefit and the need for longer-term evaluation.
cohort · n=276,8881 mentionsExpert CommentaryACC Journal Scan Highlight
JUL 11FauchierEuropean Heart Journal
Influenza vaccination linked to a ~20% lower risk of incident AF versus no vaccination.
Influenza vaccination was associated with lower incident AF risk; supports hypothesis generation but should not yet change practice.
AJACC Journal Scan
...these findings support consideration of influenza vaccination as part of comprehensive cardiovascular and [AFib] prevention strategies in routine care.
GuidelineExpert CommentaryACC Journal Scan Highlight
JUL 20AndersonJAMA
Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy
Randomized trial assesses the impact of the 2026 dyslipidemia guideline on statin eligibility in US adults, indicating significant increases in eligible populations.
Guideline1 mentionsExpert CommentaryFeatured in Podcast
JUL 1RizikКАРДИОЛОГИЯ УЗБЕКИСТАНА
SCAI/ASE/HRS/SIR/SVS Expert Consensus Statement on Enhanced Radiation Protection
Expert consensus calls for mandatory enhanced radiation protection in fluoroscopy labs, highlighting safety and regulatory needs.
GuidelineExpert CommentaryACC Journal Scan Highlight
JUL 20AbohashemJAMA
Prevalence of LDL-C Above 2026 Dyslipidemia Guideline Goals Among US Adults
Cross-sectional study examines LDL-C levels exceeding guidelines in adults, indicating important health implications.
cohort · n=55,7689 mentionsExpert CommentaryACC Journal Scan Highlight
JUL 1SanghviJournal of the American College of Cardiology
Higher sarcopenic obesity index linked to ~31% greater risk of incident heart failure and mortality.
Sarcopenic obesity indexing on routine CMR may refine risk stratification; leaves open whether targeting it improves outcomes.
AJACC Journal Scan
[Sarcopenic obesity] is emerging as a systemic cardiometabolic phenotype linking ageing, impaired muscle biology, heart failure vulnerability and frailty. By enabling scalable opportunistic quantification of muscle mass from routine CMR, Sanghvi et al., provide proof of concept that deep learning...